Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa G Lechner

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Nature Reviews. Endocrinology|September 2, 2021
Insights into immune checkpoint inhibitor-induced thyroiditisMelissa G Lechner, Mabel Ryder
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2011
A new mechanism for blocking myeloid-derived suppressor cells by CpGMelissa G Lechner, Alan L Epstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2024
A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid CancerMelissa G Lechner, Gregory A Brent
Surgical Pathology Clinics|November 2, 2019
Treatment of Differentiated Thyroid CarcinomasMelissa G Lechner, Stephanie Smooke Praw, Trevor E Angell
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2010
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cellsMelissa G Lechner, Daniel J Liebertz, Alan L Epstein
The New England Journal of Medicine|January 31, 2019
Bridging the GapJessica T Lee, Melissa G Lechner, Anand Vaidya, et al.
Annual Review of Immunology|January 5, 2022
Sex Differences in ImmunityNicole M Wilkinson, Ho-Chung Chen, Melissa G Lechner, et al.
Immunotherapy|November 8, 2011
Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumorsMelissa G Lechner, Sarah M Russell, Rikki S Bass, et al.
Pediatrics|March 11, 2022
Polyendocrine Autoimmunity and Diabetic Ketoacidosis Following Anti-PD-1 and Interferon αAditi Dasgupta, Eric Tsay, Noah Federman, et al.
AACE Clinical Case Reports|September 22, 2023
Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor-Induced ThyroiditisDennis H Chen, Heinz-Josef Lenz, Melissa G Lechner, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Nature Reviews. Endocrinology|September 2, 2021
Insights into immune checkpoint inhibitor-induced thyroiditisMelissa G Lechner, Mabel Ryder
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2011
A new mechanism for blocking myeloid-derived suppressor cells by CpGMelissa G Lechner, Alan L Epstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2024
A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid CancerMelissa G Lechner, Gregory A Brent
Surgical Pathology Clinics|November 2, 2019
Treatment of Differentiated Thyroid CarcinomasMelissa G Lechner, Stephanie Smooke Praw, Trevor E Angell
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2010
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cellsMelissa G Lechner, Daniel J Liebertz, Alan L Epstein
The New England Journal of Medicine|January 31, 2019
Bridging the GapJessica T Lee, Melissa G Lechner, Anand Vaidya, et al.
Annual Review of Immunology|January 5, 2022
Sex Differences in ImmunityNicole M Wilkinson, Ho-Chung Chen, Melissa G Lechner, et al.
Immunotherapy|November 8, 2011
Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumorsMelissa G Lechner, Sarah M Russell, Rikki S Bass, et al.
Pediatrics|March 11, 2022
Polyendocrine Autoimmunity and Diabetic Ketoacidosis Following Anti-PD-1 and Interferon αAditi Dasgupta, Eric Tsay, Noah Federman, et al.
AACE Clinical Case Reports|September 22, 2023
Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor-Induced ThyroiditisDennis H Chen, Heinz-Josef Lenz, Melissa G Lechner, et al.
Pageof 6